Enzymotec's InCog(TM), an Innovative Lipid Composition for Cognitive Functioning, Approved as Novel Food in Europe
December 01, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Dec. 1, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
Enzymotec Ltd. Reports Third Quarter 2015 Results
November 11, 2015 07:30 ET
|
Enzymotec Ltd.
Earns non-GAAP $0.08 and GAAP $0.07 per Diluted Share and Generates $4.7 Million in Operating Cash Flow
VAYA Pharma Generates Record Net Revenues of $2.2 Million
MIGDAL HA'EMEQ, Israel, Nov. 11,...
Enzymotec to Host a VAYA Pharma Analyst and Investor Day in New York City on November 19, 2015
November 10, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid-based nutritional ingredients and medical...
Retrospective Analysis of the Effects of Enzymotec's Vayarin(R) Showed Significant Improvement of Emotional Status and Sleep Quality in ADHD Patients With Sleep Disturbances
November 09, 2015 09:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enyzmotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid-based...
Enzymotec to Report Third Quarter 2015 Financial Results
October 28, 2015 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
Enzymotec Ltd. Granted a New US Patent for Vayacog(R) in Pre-Dementia
October 28, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
Enzymotec Ltd. Granted U.S. Patent for INFAT(R) to Promote Intestinal Development and Maturation
August 19, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
Enzymotec Ltd. Reports Second Quarter 2015 Results
August 12, 2015 07:30 ET
|
Enzymotec Ltd.
Revenues and Adjusted EBITDA Increased for Fourth Consecutive Quarter
Q2 Net Revenues Increased 49.5% Year-Over-Year; Q2 Net Income of $0.10 Per Diluted Share
MIGDAL HA'EMEQ, Israel, Aug. 12,...
Enzymotec Ltd. Announces the Appointment of Tamar Howson to Its Board of Directors
July 30, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 30, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced...
Enzymotec to Report Second Quarter 2015 Financial Results
July 29, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 29, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (NASDAQ:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...